KÖSEOĞLU, E. Et Al. 2021. Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51 , 418.

KÖSEOĞLU, E., SUNGUR, N., MUHTAROĞLU, S., & EKEN, A., (2021). Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice. EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 418.

KÖSEOĞLU, Emel Et Al. "Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice," EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, 418, 2021

KÖSEOĞLU, Emel Et Al. "Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.418, 2021

KÖSEOĞLU, E. Et Al. (2021) . "Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice." EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, p.418.

@article{article, author={Emel KÖSEOĞLU Et Al. }, title={Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice}, journal={EUROPEAN JOURNAL OF IMMUNOLOGY}, year=2021, pages={418} }